ARK Genomic Revolution ETF vs Bumble Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.37, while Bumble Inc trades at $2.63 (market cap $366.87M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Bumble Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | BMBL | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $7.17 |
52-Week Low | $24.02 | $2.70 |
Market Cap | — | $366.87M |
Enterprise Value | — | $672.73M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Bumble (BMBL) trades at $2.62, down 4.03% on the day, reflecting ongoing investor concerns. The stock is in a bearish technical trend with negative earnings and declining revenue. Recent strategic shifts, including removing the women-first messaging rule and exploring a sale, aim to revive growth amid falling paying users. Valuation ratios like P/S of 0.38 and P/B of 0.71 appear low, but profitability remains weak with a net income margin of -57.96%.
The outlook is cautious; while cost controls and product changes could stabilize the business, persistent losses and competitive pressures pose significant risks. Analyst consensus is mixed with a $3.62 price target, but high institutional selling and bearish sentiment suggest limited near-term upside. Investors should weigh potential turnaround against execution risks and market skepticism.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come on a monthly basis to discover new people and connect with each other.
Read more on BMBL →